About Cremaffin
Cremaffin is a Healthcare company. Provision of constipation relief products and services is handled by Cremaffin. The company has 3,696 employees. Its Indian entity Abbott India Limited reported revenue of ₹7,249 Cr. Cremaffin offers products and services including Cremaffin Syrup and Cremaffin Tablets. Its focus areas include Wellness, Over-the-Counter Products, Laxatives and Pharmaceuticals.
Company details
Cremaffin is identified as a brand that offers gentle and effective relief from constipation through its syrup and tablets containing Milk of Magnesia, which draws water into the intestine to facilitate bowel movement. It is recognized as the doctors top recommended option for non-habit forming 3-in-1 relief, addressing symptoms like hard stools and irregular patterns. Customer experiences highlight its reliability in managing lifestyle-induced issues, such as those from busy routines and poor diets, without promoting dependency. This approach ensures constipation is alleviated efficiently, allowing normal activities to resume.
- Employees 3,696
- SectorsHealthcare
- Email••••••••
- Legal Name Abbott India Limited
- Date of Incorporation 22 Aug, 1944
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹7,249 Cr
FY 2026 · +8% YoY
- Indian entity net profit₹1,547 Cr
FY 2026 · 21% margin
- Indian entity EBITDA₹1,892 Cr
FY 2026 · 26% margin
- Employee Count3,696
Associated legal entities of Cremaffin
Cremaffin operates through Abbott India Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abbott India Limited Listed CIN L24239MH1944PLC007330 | Active | 22 Aug 1944 | Mumbai, Maharashtra | ₹7,249 Cr | 3,924 | 15 | View details |
Products & Services of Cremaffin
Cremaffin offers a comprehensive portfolio of products and services, including Cremaffin Syrup and Cremaffin Tablets.
Syrup is offered for constipation relief using Milk of Magnesia to draw water into the intestine
Tablets are provided as a non-habit forming option for effective constipation management
Board of directors of Abbott India Limited (Cremaffin)
Abbott India Limited is the primary company behind Cremaffin. The board of Abbott India Limited currently have 11 directors; the longest-serving is Munir Shaikh, appointed in 2001. 31 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Munir Shaikh DIN 00096273 | Director | 02 Mar 2001 | 25 yrs 7 mo | Abbott India Limited |
| Kaiyomarz Minoo Marfatia DIN 03449627 | Director | 01 Mar 2011 | 15 yrs 7 mo | Abbott India Limited |
| Sudarshan Kailash Chandra Jain DIN 00927487 | Director | 01 Apr 2019 | 7 yrs 6 mo | Abbott India Limited |
| Shalini Kalsi Kamath DIN 06993314 | Director | 29 Oct 2019 | 6 yrs 11 mo | Abbott India Limited |
| Alison Elizabeth Davies DIN 10658884 | Director | 13 Jun 2024 | 2 yrs 4 mo | Abbott India Limited |
| Maithilee Kaizad Mistry DIN 02152619 | CFO | 06 May 2025 | 1 yr 5 mo | Abbott India Limited |
| Kartik Rajendran DIN 09527717 | Managing Director | 14 Jun 2025 | 1 yr 4 mo | Abbott India Limited |
| Darshan Pravin Gada DIN 08174581 | Director | 18 Aug 2025 | 1 yr 2 mo | Abbott India Limited |
| Vivek Mohan DIN 00075006 | Director | 01 Jan 2026 | 9 mo | Abbott India Limited |
| James Russell Wenner DIN 11650998 | Director | 23 Apr 2026 | 6 mo | Abbott India Limited |
| Neeraj Jain DIN 00348591 | Director | 25 Apr 2026 | 6 mo | Abbott India Limited |
Financials of Cremaffin
Figures of Abbott India Limited, the primary company behind Cremaffin, for FY 2026. Revenue was ₹7,249 Cr (+8% year on year). Net profit was ₹1,547 Cr (21% margin). EBITDA was ₹1,892 Cr (26% margin). Revenue has grown at a compounded annual rate of +9% over three years and +10% over five years.
- ₹7,249 CrRevenue · FY 2026 · +8% YoY
- ₹1,547 CrNet profit · 21% margin
- ₹1,892 CrEBITDA · 26% margin
- ₹21.25 CrPaid-up capital
- 3,924Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abbott India Limited are on its company page.
Detailed financial statements for Cremaffin
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cremaffin
Complete news archive for Cremaffin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cremaffin
Cremaffin has 3,696 employees.
The primary company behind Cremaffin, Abbott India Limited, reported revenue of ₹7,249 Cr for FY 2026, up 8% year on year.
Cremaffin is identified as a brand that offers gentle and effective relief from constipation through its syrup and tablets containing Milk of Magnesia, which draws water into the intestine to facilitate bowel movement. It is recognized as the doctors top recommended option for non-habit forming 3-in-1 relief, addressing symptoms like hard stools and irregular patterns. Customer experiences highlight its reliability in managing lifestyle-induced issues, such as those from busy routines and poor diets, without promoting dependency. This approach ensures constipation is alleviated efficiently, allowing normal activities to resume.
Cremaffin offers Cremaffin Syrup and Cremaffin Tablets.
Cremaffin operates through Abbott India Limited.
The legal entities of Cremaffin currently have 14 directors, including Sridhar Venkateswaran Kadangode, Munir Shaikh, Neeraj Jain and others.